Drägerwerk AG & Co. KGaA

  • WKN: 555060
  • ISIN: DE0005550602
  • Land: Deutschland

Nachricht vom 25.11.2021 | 13:15

Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052

DGAP-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous
25.11.2021 / 13:15
The issuer is solely responsible for the content of this announcement.

Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
Purchase of own shares - final notice


In the period 2 November 2021 to 24 November 2021 (inclusive) a total of 89,308 preferred shares were bought back within the framework of the share buyback of Drägerwerk AG & Co. KGaA ("Dräger"). In accordance with Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052, the start date of the buyback was announced for 1 October 2021.

The share buyback is completed.

The acquisition of the preferred shares served the purpose of fulfilling obligations relating to an employee participation program within the meaning of article 5, paragraph 2 (c) of the Regulation (EU) No 596/2014.

A bank mandated by Dräger conducted the buyback of the Dräger preference shares exclusively on a stock exchange.

In the period from 2 November 2021 to 24 November 2021, the daily number of preferred shares bought back, weighted average share price and aggregated volume totaled:

Date Total number of shares bought back Weighted average share price (EUR) Aggregated volume
(EUR)
02 Nov. 2021 6,032 68.12 410,927.80
03 Nov. 2021 5,882 68.97 405,695.20
04 Nov. 2021 5,990 70.26 420,842.65
05 Nov. 2021 5,746 69.77 400,879.30
06 Nov. 2021 2,500 68.98 172,460.00
09 Nov. 2021 1,870 68.80 128,653.50
10 Nov. 2021 1,776 69.07 122,676.50
11 Nov. 2021 7,512 69.29 520,519.50
12 Nov. 2021 806 69.61 56,105.20
13 Nov. 2021 4,444 69.15 307,307.44
16 Nov. 2021 4,366 70.27 306,788.75
17 Nov. 2021 2,884 69.88 201,546.20
18 Nov. 2021 2,554 70.24 179,396.20
19 Nov. 2021 3,946 71.21 280,977.80
20 Nov. 2021 3,000 70.33 210,985.90
23 Nov. 2021 4,605 68.39 314,941.75
24 Nov.2021 25,395 59.50 1,511,046.51
Total: 89,308   5,951,750.20
 


In accordance with Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052, information about the transactions is available on the Company's website (www.draeger.com) in the Investor Relations section (www.draeger.com/en_corp/Investor-Relations/Share).

Lübeck, Germany, 24 November 2021

Executive Board
Drägerwerk Verwaltungs AG, acting as the general partner of
Drägerwerk AG & Co. KGaA

Moislinger Allee 53-55
23558 Lübeck, Germany
www.draeger.com



25.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021